Table 1 Demographic characteristics and mean symptom severity scores of study participants.
Characteristics | Healthy controls | Close contacts | Mild disease | Moderate disease |
|---|---|---|---|---|
A. Bulk assays for ATAC-seq and RNA-seq | ||||
Number of subjects | 7 | 7 | 8 | 7 |
Age Mean (range), years | 39.7 (25–61) | 42.9 (17–61) | 33.0 (27–60) | 34.0 (20–52) |
Sex (male/female) | 3/4 | 4/3 | 5/3 | 3/4 |
Max severity score (± SE) | N/A | 9.9 ± 2.9 | 12.8 ± 1.9 | 33.6 ± 2.4 |
Characteristics | Healthy controls | Close contacts | Mild disease | Moderate disease |
|---|---|---|---|---|
B. Single cell assays for ATAC-seq/RNA-seq | ||||
Number of subjects | 5 | 3 | 5 | 5 |
Age Mean (range), years | 45.2 (28–61) | 53.2 (43–61) | 35.6 (27–60) | 37.7 (29–52) |
Sex (male/female) | 1/4 | 2/1 | 5/0 | 1/4 |
Max severity score (± SE) | N/A | 3.3 ± 2.8 | 12.2 ± 2.8 | 36.0 ± 2.3 |
